Cardinal Health, Inc (NYSE: CAH)’s stock price has increased by 3148616 compared to its previous closing price of 163.99. However, the company has seen a 1.11% increase in its stock price over the last five trading sessions. zacks.com reported 2025-06-19 that Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock’s price, do they really matter?
Is It Worth Investing in Cardinal Health, Inc (NYSE: CAH) Right Now?
Cardinal Health, Inc (NYSE: CAH) has a price-to-earnings ratio that is above its average at 25.64x. The stock has a 36-month beta value of 0.68. Opinions on the stock are mixed, with 10 analysts rating it as a “buy,” 2 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for CAH is 238.00M, and at present, short sellers hold a 2.48% of that float. On June 25, 2025, the average trading volume of CAH was 2.49M shares.
CAH’s Market Performance
The stock of Cardinal Health, Inc (CAH) has seen a 1.11% increase in the past week, with a 7.69% rise in the past month, and a 23.27% gain in the past quarter. The volatility ratio for the week is 0.75%, and the volatility levels for the past 30 days are at 1.19% for CAH. The simple moving average for the past 20 days is 4.05% for CAH’s stock, with a 27.96% simple moving average for the past 200 days.
Analysts’ Opinion of CAH
Many brokerage firms have already submitted their reports for CAH stocks, with Wells Fargo repeating the rating for CAH by listing it as a “Overweight.” The predicted price for CAH in the upcoming period, according to Wells Fargo is $179 based on the research report published on June 03, 2025 of the current year 2025.
Jefferies, on the other hand, stated in their research note that they expect to see CAH reach a price target of $150, previously predicting the price at $140. The rating they have provided for CAH stocks is “Buy” according to the report published on February 05th, 2025.
TD Cowen gave a rating of “Buy” to CAH, setting the target price at $144 in the report published on January 08th of the current year.
CAH Trading at 9.70% from the 50-Day Moving Average
After a stumble in the market that brought CAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.27% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CAH starting from Scherer Mary C., who sale 3,504 shares at the price of $123.55 back on Nov 14 ’24. After this action, Scherer Mary C. now owns 8,752 shares of Cardinal Health, Inc, valued at $432,919 using the latest closing price.
Mayer Jessica L, the Chief Legal/Compliance Officer of Cardinal Health, Inc, sale 16,573 shares at $109.39 during a trade that took place back on Aug 21 ’24, which means that Mayer Jessica L is holding 75,971 shares at $1,812,920 based on the most recent closing price.
Stock Fundamentals for CAH
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.03 for the gross margin
The net margin for Cardinal Health, Inc stands at 0.01. The total capital return value is set at 0.18.
Based on Cardinal Health, Inc (CAH), the company’s capital structure generated 1.62 points at debt to capital in total, while cash flow to debt ratio is standing at 0.38. The debt to equity ratio resting at -2.6. The interest coverage ratio of the stock is 15.45.
Currently, EBITDA for the company is 1.98 billion with net debt to EBITDA at 1.55. When we switch over and look at the enterprise to sales, we see a ratio of 0.2. The receivables turnover for the company is 17.55for trailing twelve months and the total asset turnover is 4.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
To sum up, Cardinal Health, Inc (CAH) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
